[Ip-health] Results from the 10 March 2014 WHO meeting to evaluate the R&D demonstration project

Thiru Balasubramaniam thiru at keionline.org
Tue Mar 18 05:21:32 PDT 2014



"Meeting to Examine Additional Information Received - 10 March 2014

The meeting to examine the additional information received in relation to
the 7+1 demonstration projects identified by the Global Technical
Consultative Meeting took place on 10 March 2014 at WHO headquarters. The
former Chair and Vice-Chair of the CEWG, facilitated by the Secretariat and
observed by Member States, assessed the 7+1 identified projects based on
the 6 additional questions posed to proponents. The purpose of this
assessment was to determine which of the 8 proposals were ready enough to
move forward with stakeholder meetings before the World Health Assembly and
which required more work.

Based on this assessment, it was determined that the Secretariat will move
forward with convening stakeholder meetings for the following 4 proposals:

   - *The Visceral Leishmaniasis (VL) Global R&D & Access Initiative* -
   Drugs for Neglected Diseases initiative (DNDi), submitted via AFRO and EMRO.
   - *Exploiting the Pathogen Box: an international open source
   collaboration to accelerate drug development in addressing diseases of
   poverty* - Medicines for Malaria Venture (MMV), submitted via EURO.
   - *Development of Class D Cpg Odn (D35) as an Adjunct to Chemotherapy
   for Cutaneous Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis
(Pkdl) *-
   United States Food and Drug Administration (US FDA), et al., submitted via
   - *Development for Easy to Use and Affordable Biomarkers as Diagnostics
   for Types II and III Diseases *- African Network for Drugs and
   Diagnostics Innovation (ANDI), et al., submitted via AFRO.

Noting the significant public health impact and scientific and technical
merit of the remaining 4 projects, it was agreed that although these
projects are not ready enough to move forward to the implementation stage,
the Secretariat will assist the proponents of these proposals in improving
the innovative aspects of their projects (if they so desire):

   - *Multiplexed Point-of-Care test for acute febrile illness* -
   Translational Health Science and Technology Institute (THSTI), India, et
   al., submitted via SEARO.
   - *Demonstration of the potential of a single dose malaria cure of
   artemether-lumefantrine through reformulation in a nano-based drug delivery
   system *- Council for Industrial and Scientific Research, South Africa,
   et al., submitted via AFRO.
   - *Development of a Vaccine Against Schistosomiasis Based on the
   Recombinant Sm14 A Member of the Fatty Acid Binding Protein: Controlling
   Transmission of a Disease of Poverty *- Oswaldo Cruz Foundation
   (Fiocruz), et al., submitted via AMRO.
   - *Dengue vaccine development* - Health Systems Research Institute
   (HSRI), Thailand, et al., submitted via SEARO."

More information about the Ip-health mailing list